<b>Aim:</b> As intrinsic resistance - often driven by concurrent genomic alterations in tumor suppressor genes or oncogenes - remains a major challenge in oncology, this work aimed to comprehensively analyze <i>BRAF</i> somatic alterations across cancer types and identify new potential therapeutic strategies to overcome drug resistance. The gene discussed is BRAF; the disease is neoplasm.